Clinical Trial

The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-22.
Trial Details
NCT Number NCT06704334
Lead Sponsor Wanbangde Pharmaceutical Group Co., LTD
Collaborators: Ganzhou City People's Hospital
Conditions Cognitive Impairment After Brain Injury
Enrollment 50 participants
Start Date 2024-04-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-11